drugset / Trial / NCT01397500

Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

NCT01397500

RandomizedParallel-groupDouble-blindTreatment

Summary

Growth hormone and gonadotropin deficiency after brain injury (traumatic brain injury, ischemic stroke, subarachnoidal hemorrhage): the effects of hormone replacement on cognition, quality of life and body composition Randomized, controlled, 3 arm (group 2: double-blind; groups 1 and 3: open), multi-center, pilot study (Phase II)

Timeline

Start
2011-11
Primary completion
2015-02
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.2 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 0.3 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 0.4 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 0.5 mg Subcutaneous
Comparator Testosterone undecannoate Unknown 1000 mg Intramuscular

Indications